A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
BACKGROUND:Neoadjuvant chemotherapy (NAC) allows earlier treatment of rectal cancer micro-metastases but is not standard of care. There are currently no biomarkers predicting long-term progression-free survival (PFS) benefit from NAC. PATIENTS AND METHODS:In this single arm phase II trial, patients...
Հիմնական հեղինակներ: | Gollins, S, West, N, Sebag-Montefiore, D, Susnerwala, S, Falk, S, Brown, N, Saunders, M, Quirke, P, Ray, R, Parsons, P, Griffiths, G, Maughan, T, Adams, R, Hurt, C |
---|---|
Այլ հեղինակներ: | McIntyre, A |
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Springer Nature
2019
|
Նմանատիպ նյութեր
-
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
: Mukherjee, S, և այլն
Հրապարակվել է: (2017) -
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
: Glynne-Jones, R, և այլն
Հրապարակվել է: (2007) -
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
: Sebag-Montefiore, D, և այլն
Հրապարակվել է: (2005) -
Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
: Glynne-Jones, R, և այլն
Հրապարակվել է: (2004) -
Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
: Glynne-Jones, R, և այլն
Հրապարակվել է: (2005)